BioAdvance PortfolioBioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its $20 million Greenhouse Fund.  We invest in therapeutics, devices, diagnostics and platform technologies focused on human health.

Apply For FundingSince its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date we have committed $24.1 million to 35 seed-stage companies and 21 pre-seed investments. Our portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance investments have enabled its portfolio companies to leverage more than $1.5 billion in subsequent capital into the region (from private equity, grants, collaborations and M&A activity).